These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 11192820)

  • 1. Mifepristone for termination of early pregnancy.
    FDA Consum; 2000; 34(6):7. PubMed ID: 11192820
    [No Abstract]   [Full Text] [Related]  

  • 2. The long, winding road of RU-486.
    Check E
    Newsweek; 2000 Oct; 136(14):50. PubMed ID: 11183341
    [No Abstract]   [Full Text] [Related]  

  • 3. A little pill but a big dispute.
    Whitman D; Schultz S
    US News World Rep; 2000 Oct; 129(14):18-9, 22. PubMed ID: 11183344
    [No Abstract]   [Full Text] [Related]  

  • 4. The pill arrives.
    Gibbs N
    Time; 2000 Oct; 156(15):40-6, 49. PubMed ID: 11184532
    [No Abstract]   [Full Text] [Related]  

  • 5. The abortion pill.
    France D; Rosenberg D
    Newsweek; 2000 Oct; 136(15):26-30. PubMed ID: 11184536
    [No Abstract]   [Full Text] [Related]  

  • 6. Medical abortion practices: a survey of National Abortion Federation members in the United States.
    Wiegerinck MM; Jones HE; O'Connell K; Lichtenberg ES; Paul M; Westhoff CL
    Contraception; 2008 Dec; 78(6):486-91. PubMed ID: 19014795
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The approval of mifepristone (RU486) in the United States: What's wrong with this picture?
    Blumenthal P; Johnson J; Stewart F
    Medscape Womens Health; 2000; 5(4):E7. PubMed ID: 11109052
    [No Abstract]   [Full Text] [Related]  

  • 8. Her accidental legacy.
    Rosenberg D
    Newsweek; 2003 Oct; 142(15):64. PubMed ID: 16124192
    [No Abstract]   [Full Text] [Related]  

  • 9. Approval of mifepristone (RU 486) in Europe.
    Sitruk-Ware R
    Zentralbl Gynakol; 2000; 122(5):241-7. PubMed ID: 10857210
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Abortion pill gets FDA approval.
    SoRelle R
    Circulation; 2000 Oct; 102(15):E9030-1. PubMed ID: 11183868
    [No Abstract]   [Full Text] [Related]  

  • 11. Comment: analysis of severe adverse events related to the use of mifepristone as an abortifacient.
    Hausknecht RU
    Ann Pharmacother; 2006 Apr; 40(4):785-6; author reply 786. PubMed ID: 16569806
    [No Abstract]   [Full Text] [Related]  

  • 12. Mifepristone: less obvious adverse effects.
    Rudd G
    Ann Pharmacother; 2001 Mar; 35(3):381-2. PubMed ID: 11261540
    [No Abstract]   [Full Text] [Related]  

  • 13. Two mifepristone doses and two intervals of misoprostol administration for termination of early pregnancy: a randomised factorial controlled equivalence trial.
    von Hertzen H; Piaggio G; Wojdyla D; Marions L; My Huong NT; Tang OS; Fang AH; Wu SC; Kalmar L; Mittal S; Erdenetungalag R; Horga M; Pretnar-Darovec A; Kapamadzija A; Dickson K; Anh ND; Tai NV; Tuyet HT; Peregoudov A;
    BJOG; 2009 Feb; 116(3):381-9. PubMed ID: 19187370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mifepristone--a boom or a bust?
    Willke JC
    Ann Pharmacother; 2001 Mar; 35(3):376-80. PubMed ID: 11261539
    [No Abstract]   [Full Text] [Related]  

  • 15. Comment: analysis of severe adverse events related to the use of mifepristone as an abortifacient.
    Shannon CS
    Ann Pharmacother; 2006 Jun; 40(6):1215-6; author reply 1216-7. PubMed ID: 16735658
    [No Abstract]   [Full Text] [Related]  

  • 16. Medical abortion at 57 to 63 days' gestation with a lower dose of mifepristone and gemeprost. A randomized controlled trial.
    World Health Organization Task Force on Post-ovulatory Methods of Fertility Regulation
    Acta Obstet Gynecol Scand; 2001 May; 80(5):447-51. PubMed ID: 11328223
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Abortifacient drug approved for restricted, physician-only distribution.
    Miller JL
    Am J Health Syst Pharm; 2000 Nov; 57(21):1940. PubMed ID: 11094643
    [No Abstract]   [Full Text] [Related]  

  • 18. Randomised controlled trial comparing the efficacy of same-day administration of mifepristone and misoprostol for termination of pregnancy with the standard 36 to 48 hour protocol.
    Guest J; Chien PF; Thomson MA; Kosseim ML
    BJOG; 2007 Feb; 114(2):207-15. PubMed ID: 17305893
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-awaited abortion pill will offer more privacy--but no less controversy.
    Schultz S
    US News World Rep; 2000 Feb; 128(8):79-80. PubMed ID: 11184124
    [No Abstract]   [Full Text] [Related]  

  • 20. Time to Reevaluate U.S. Mifepristone Restrictions.
    Henney JE; Gayle HD
    N Engl J Med; 2019 Aug; 381(7):597-598. PubMed ID: 31242357
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.